Skip to main content
. 2022 Jan 20;12:1085. doi: 10.1038/s41598-022-04916-6

Figure 5.

Figure 5

Effect of BEZ-235 on PI3K/AKT activity and on expression of BCL2 family members. Western blots (12% PAA gel) showing (a) dose- and (b) time-dependent effects of BEZ-235 on the expression of BCL2 family members and on phosphorylation of AKT, the mTOR target S6 and the BCL2 family member BAD. Dose-dependent effects were assessed after 24 h, time-dependent effects with a concentration of 300 nM BEZ-235. (c) Kinetics of apoptosis induced by BEZ-235 and AZD-5991 as determined by caspase 3/7 activity. Note that the kinetics of caspase 3/7 activity stimulated by BEZ-235 and AZD-5991 do not differ.